Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -1.37% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -50.47%. Over the past 30 days, the price of OLMA has leaped by -44.98%. And in the last five days, it has fallen by -1.37%.
Olema Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $16.77 on 02/13/24 and the lowest value was $5.06 on 01/07/25.
52-week price history of OLMA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Olema Pharmaceuticals Inc’s current trading price is -65.72% away from its 52-week high, while its distance from the 52-week low is 13.64%. The stock’s price range during this period has varied between$5.06 and $16.77. The Olema Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.18 million for the day, a figure considerably higher than their average daily volume of 0.78 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Olema Pharmaceuticals Inc (OLMA) has experienced a quarterly decline of -49.56% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 426.90M and boasts a workforce of 74 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.46, with a change in price of -6.64. Similarly, Olema Pharmaceuticals Inc recorded 709,972 in trading volume during the last 100 days, posting a change of -53.59%.
OLMA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for OLMA stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
OLMA Stock Stochastic Average
As of today, Olema Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 8.17%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 14.59%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 6.39% and 4.96%, respectively.
